Assessing Efficacy of the Rothman Index

Withdrawn before enrolling · Not applicable

Conditions studied: Inpatients Who Generate at Least Two Rothman Index Scores

In brief

This study is designed to assess the efficacy of the Rothman Index in combination with a set of recommended-use protocols to improve rates of mortality and/or rates of discharge to hospice care in hospitalized patients.

Key facts

Study ID

NCT04403737

Run by

Yale University

People needed

0

Starts

2021-11-01

Expected to finish

2023-06-01

Last updated by the study team

2022-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults inpatients greater than or equal to 18 years of age
• Admitted to any inpatient unit at two study sites within the Yale New Haven Health System
• Has generated at least 2 Rothman Index scores during the present hospital admission

You may not qualify if…

• Prior admission in which patient was randomized
• Patient has opted out of electronic health record consent
• Patient in observation status
• Patient admitted to hospice service

Where it is running

• Greenwich Hospital — Greenwich, Connecticut, United States
• Lawrence + Memorial Hospital — New London, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.